癌细胞通过获得血小板线粒体重新编程到转移状态
Wenkan Zhang1, Hao Zhou1, Hengyuan Li1
1Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, China; Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou, Zhejiang, China.
Cell reports
|September 27, 2023
概括
血小板将线粒体转移到癌细胞,重新编程它们进行转移. 针对血小板线粒体功能的治疗为骨髓瘤肺转移提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 线粒体医学 线粒体医学
背景情况:
- 转移是癌症死亡的主要原因.
- 血小板对于瘤的进展和转移至关重要.
- 了解癌细胞适应瘤微环境是有效治疗的关键.
研究的目的:
- 为了研究血小板线粒体在癌细胞转移中的作用.
- 阐明线粒体从血小板转移到癌细胞的机制.
- 探索针对血小板线粒体的治疗策略,用于骨髓瘤治疗.
主要方法:
- 通过PINK1/Parkin-Mfn2途径研究了线粒体的转移.
- 评估了血小板线粒体对癌细胞氧化还原平衡 (GSH/GSSG比) 和活性氧物种 (ROS) 的影响.
- 评估了损害血小板线粒体功能对骨髓瘤肺转移的影响.
主要成果:
- 癌细胞获得了血小板线粒体,促进了转移性表型.
- 血小板线粒体调节癌细胞GSH/GSSG比率和ROS水平.
- 抑制血小板线粒体功能可以有效地减少骨髓瘤肺转移.
结论:
- 线粒体从血小板转移到癌细胞是一种新的驱动转移的机制.
- 血小板线粒体在调节癌细胞转移潜力的过程中起着重要作用.
- 针对血小板线粒体功能的治疗为骨髓瘤提供了一个有前途的治疗途径.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


